Clinical Trial Update: DE-111 Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating DE-111 ophthalmic solution for open-angle glaucoma or ocular hypertension has been completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• DE-111 Ophthalmic Solution (DE-111 ophthalmic solution)

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Open Angle Glaucoma or Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2015-05-14